This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Sanofi branded clouded background image

Latest Education

Education23 Oct 2023

What Insulins Do I Need In My Toolbox To Support People With Type 2 Diabetes

Lantus® (insulin glargine 100 units/mL) Prescribing Information UK Toujeo® (insulin glargine 300 units/mL) Prescribing Information UK

Education23 Oct 2023

New Approaches and Innovation in Lipid Services – Strengthening the Relationship between Primary and Secondary Care

Praluent® (alirocumab) Prescribing Information (GB)Praluent® (alirocumab) Prescribing Information (NI)

Education23 Oct 2023

What the InRange Study Can Teach Us About Time-In-Range (TIR)

Toujeo® (insulin glargine 300 units/mL) Prescribing Information

Education23 Oct 2023

Practicalities of Supporting the Teenager With Type 2 Diabetes

Toujeo® (insulin glargine 300 units/mL) Prescribing Information Lantus® (insulin glargine 100 units/mL) Prescribing Information

Education23 Oct 2023

Diabetes UK 2023: Diabetes & Exercise Masterclass: supporting your patients with Type 1 diabetes on a MDI and CGM with their exercise goals

Lantus® (insulin glargine 100 units/mL) Prescribing Information UK Toujeo® (insulin glargine 300 units/mL) Prescribing Information UK

Education23 Oct 2023

Diabetes UK 2023: Multifactorial approach to diabetes management

Education23 Oct 2023

Diabetes Podcast Series | Toujeo® (insulin glargine 300 Units/mL) | Lantus® (insulin glargine 100 units/mL)

Promotional podcasts on a variety of different topics and meetings that have been organised and funded by Sanofi

Prescribing Information Toujeo (insulin glargine 300 units/mL)Prescribing Information Lantus (insulin glargine 100 units/mL)

Education23 Oct 2023

Diabetes UK 2023: Cultural humility in diabetes consultation

MAT-XU-2305049 (v2.0) Date of preparation: February 2024

Therapeutic Areas
- Cardiology
  - Dyslipidaemia
  - Thrombosis
- Dermatology
  - Atopic Dermatitis
- Diabetes
  - Type 1 Diabetes
  - Type 2 Diabetes
- Neurology
  - Multiple Sclerosis
- Oncology
  - Multiple Myeloma
  - Other Oncology Topics
- Rare Disease
- Respiratory
  - Asthma
  - COPD
- Transplant
  - Transplant
- Vaccines
- Other Topics
  - General Topics
  - Payor
Articles
- Cardiology
  - Dyslipidaemia
  - Thrombosis
- Dermatology
  - Atopic Dermatitis
- Diabetes
  - Type 1 Diabetes
  - Type 2 Diabetes
- Neurology
  - Multiple Sclerosis
- Oncology
  - Multiple Myeloma
  - Other Oncology Topics
- Rare Disease
- Respiratory
  - Asthma
  - COPD
- Transplant
  - Transplant
- Vaccines
  - Influenza
- Other Topics
  - General Topics
Resources
- Cardiology
  - Dyslipidaemia
- Dermatology
  - Atopic Dermatitis
- Diabetes
  - Type 1 Diabetes
- Oncology
  - Multiple Myeloma
- Rare Disease
  - Gaucher
- Vaccines
- Other Topics
  - Payor
Tools
- Dermatology
  - Atopic Dermatitis
- Respiratory
  - Asthma
Events
- Diabetes
  - Type 2 Diabetes
Education
- Cardiology
  - Dyslipidaemia
- Diabetes
  - Type 1 Diabetes
  - Type 2 Diabetes
- Transplant
  - Transplant
- Vaccines
  - Other Vaccines Topics
Products